These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34751803)

  • 1. Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches.
    Maiti R; Mishra A; Mishra BR; Jena M
    Psychopharmacology (Berl); 2021 Dec; 238(12):3347-3356. PubMed ID: 34751803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression.
    Brennan BP; Jensen JE; Hudson JI; Coit CE; Beaulieu A; Pope HG; Renshaw PF; Cohen BM
    J Clin Psychopharmacol; 2013 Oct; 33(5):627-35. PubMed ID: 23948785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
    BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.
    Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
    Can J Psychiatry; 2021 Mar; 66(3):274-288. PubMed ID: 33174452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranking treatments in frequentist network meta-analysis works without resampling methods.
    Rücker G; Schwarzer G
    BMC Med Res Methodol; 2015 Jul; 15():58. PubMed ID: 26227148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of interventions for major depression in older persons: protocol for Bayesian network meta-analysis.
    Liew TM; Lee CS
    BMJ Open; 2018 Jan; 8(1):e019819. PubMed ID: 29358451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
    Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
    BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis.
    Xu H; Du Y; Wang Q; Chen L; Huang J; Liu Y; Zhou C; Du B
    Asian J Psychiatr; 2023 Feb; 80():103394. PubMed ID: 36525766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive P-score for treatment ranking in Bayesian network meta-analysis.
    Rosenberger KJ; Duan R; Chen Y; Lin L
    BMC Med Res Methodol; 2021 Oct; 21(1):213. PubMed ID: 34657593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials.
    Nery FG; Li W; DelBello MP; Welge JA
    Bipolar Disord; 2021 Nov; 23(7):707-714. PubMed ID: 33354859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
    Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
    Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania.
    Yildiz A; Nikodem M; Vieta E; Correll CU; Baldessarini RJ
    Psychol Med; 2015 Jan; 45(2):299-317. PubMed ID: 25036226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
    Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory and practice of Bayesian and frequentist frameworks for network meta-analysis.
    Sadeghirad B; Foroutan F; Zoratti MJ; Busse JW; Brignardello-Petersen R; Guyatt G; Thabane L
    BMJ Evid Based Med; 2023 Jun; 28(3):204-209. PubMed ID: 35760451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Bae SC; Lee YH
    Clin Rheumatol; 2018 Feb; 37(2):323-330. PubMed ID: 28967035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data.
    Seide SE; Jensen K; Kieser M
    Res Synth Methods; 2020 May; 11(3):363-378. PubMed ID: 31955519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Bae SC
    Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.